The Motley Fool

GlaxoSmithKline plc Could Help You Retire Early

GlaxoSmithKline‘s (LSE: GSK) (NYSE: GSK.US) recent results showed a company that is making excellent progress compared to the prior period in all regions of the world except for China.

In fact, performance in China was so bad that even the perma-bears in the healthcare sector were not anticipating a fall of 60% in revenues. Quite simply, a shock was expected and a howler was delivered.

5G is here – and shares of this ‘sleeping giant’ could be a great way for you to potentially profit!

According to one leading industry firm, the 5G boom could create a global industry worth US$12.3 TRILLION out of thin air…

And if you click here we’ll show you something that could be key to unlocking 5G’s full potential...

So, yesterday’s news that GlaxoSmithKline will be making changes across the whole company (but really aimed at appeasing China) should be seen as good news. Of course, its share price didn’t move much on the news, but it may do, in time, as GlaxoSmithKline seeks to repair the damage done to its sales in China.

China is a crucial market for most global companies and GlaxoSmithKline is no exception. Indeed, for a company to help you to retire earlier than you had anticipated, it is highly likely that they will need to be very successful in China, as it looks set to become the biggest economy in the world.

However, the decision to buy GlaxoSmithKline right now is perhaps best evaluated by focusing on the share price and concluding whether or not its shares offer good long-term value at current levels.

Indeed, GlaxoSmithKline — one of the best quality pharmaceutical companies in the world whose drug pipeline is up there with the best of them — trades at a huge discount to the healthcare industry sector to which it belongs.

This discount is wider than you may realise, with the healthcare industry sector having an average price to earnings (P/E) ratio of 19.8 and GlaxoSmithKline currently trading on a P/E of 14. In other words, GlaxoSmithKline trades at a discount of just under 30% when compared to its industry group.

Of course, this discount must partly be attributable to the problems the company is having in China and, while they may not yet have run their course, it seems as though they are priced in twice, with a little extra thrown in for good measure. Buying GlaxoSmithKline shares now could mean your pension pot ticks up nicely over the medium to long term.

“This Stock Could Be Like Buying Amazon in 1997”

I'm sure you'll agree that's quite the statement from Motley Fool Co-Founder Tom Gardner.

But since our US analyst team first recommended shares in this unique tech stock back in 2016, the value has soared.

What's more, we firmly believe there's still plenty of upside in its future. In fact, even throughout the current coronavirus crisis, its performance has been beating Wall St expectations.

And right now, we're giving you a chance to discover exactly what has got our analysts all fired up about this niche industry phenomenon, in our FREE special report, A Top US Share From The Motley Fool.

Click here to claim your copy now — and we’ll tell you the name of this Top US Share… free of charge!

Peter owns shares in GlaxoSmithKline. The Motley Fool has recommended GlaxoSmithKline.

Our 6 'Best Buys Now' Shares

The renowned analyst team at The Motley Fool UK have named 6 shares that they believe UK investors should consider buying NOW.

So if you’re looking for more stock ideas to try and best position your portfolio today, then it might be a good day for you. Because we're offering a full 33% off your first year of membership to our flagship share-tipping service, backed by our 'no quibbles' 30-day subscription fee refund guarantee.

Simply enter your email address below to discover how you can take advantage of this.

I would like to receive emails from you about product information and offers from The Fool and its business partners. Each of these emails will provide a link to unsubscribe from future emails. More information about how The Fool collects, stores, and handles personal data is available in its Privacy Statement.